These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31456478)

  • 1. Rapid change of a cohort of 570 unproven stem cell clinics in the USA over 3 years.
    Knoepfler PS
    Regen Med; 2019 Aug; 14(8):735-740. PubMed ID: 31456478
    [No Abstract]   [Full Text] [Related]  

  • 2. Texas H.B. 810: Increased Access to Stem Cell Interventions or an Increase in Unproven Treatments?
    Matthews K; Kunisetty B; Sprung K
    Stem Cells Dev; 2018 Nov; 27(21):1463-1465. PubMed ID: 30122128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping and driving the stem cell ecosystem.
    Knoepfler PS
    Regen Med; 2018 Oct; 13(7):845-858. PubMed ID: 30289055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Federal Regulatory Oversight of US Clinics Marketing Adipose-Derived Autologous Stem Cell Interventions: Insights From 3 New FDA Draft Guidance Documents.
    Turner LG
    Mayo Clin Proc; 2015 May; 90(5):567-71. PubMed ID: 25939934
    [No Abstract]   [Full Text] [Related]  

  • 5. Selling stem cell 'treatments' as research: prospective customer perspectives from crowdfunding campaigns.
    Snyder J; Turner L
    Regen Med; 2018 Jun; 13(4):375-384. PubMed ID: 29985757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. US stem cell clinics, patient safety, and the FDA.
    Turner L
    Trends Mol Med; 2015 May; 21(5):271-3. PubMed ID: 25945404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unproven but Profitable: The Boom in US Stem Cell Clinics.
    Rubin R
    JAMA; 2018 Oct; 320(14):1421-1423. PubMed ID: 30326510
    [No Abstract]   [Full Text] [Related]  

  • 8. Identity and ownership issues in the regulation of autologous cells.
    Sipp D
    Regen Med; 2017 Oct; 12(7):827-838. PubMed ID: 29115180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. US clinics marketing unproven and unlicensed adipose-derived autologous stem cell interventions.
    Turner LG
    Regen Med; 2015 May; 10(4):397-402. PubMed ID: 26022761
    [No Abstract]   [Full Text] [Related]  

  • 10. The US Direct-to-Consumer Marketplace for Autologous Stem Cell Interventions.
    Turner L
    Perspect Biol Med; 2018; 61(1):7-24. PubMed ID: 29805145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges in the Regulation of Autologous Stem Cell Interventions in the United States.
    Sipp D
    Perspect Biol Med; 2018; 61(1):25-41. PubMed ID: 29805146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDA challenges stem-cell clinic.
    Cyranoski D
    Nature; 2010 Aug; 466(7309):909. PubMed ID: 20725009
    [No Abstract]   [Full Text] [Related]  

  • 13. Unproven Stem Cell Therapies in India: Regulatory Challenges and Proposed Paths Forward.
    Tiwari SS; Desai PN
    Cell Stem Cell; 2018 Nov; 23(5):649-652. PubMed ID: 30344101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDA's claims over stem cells upheld.
    Cyranoski D
    Nature; 2012 Aug; 488(7409):14. PubMed ID: 22859178
    [No Abstract]   [Full Text] [Related]  

  • 15. From bench to FDA to bedside: US regulatory trends for new stem cell therapies.
    Knoepfler PS
    Adv Drug Deliv Rev; 2015 Mar; 82-83():192-6. PubMed ID: 25489841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicine. Monitoring and regulating offshore stem cell clinics.
    Kiatpongsan S; Sipp D
    Science; 2009 Mar; 323(5921):1564-5. PubMed ID: 19299604
    [No Abstract]   [Full Text] [Related]  

  • 17. Stem-cell scientists grapple with clinics.
    Ledford H
    Nature; 2011 Jun; 474(7353):550. PubMed ID: 21720336
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA scrutinizes human stem cell therapies.
    Fox JL
    Nat Biotechnol; 2008 Jun; 26(6):598-9. PubMed ID: 18536668
    [No Abstract]   [Full Text] [Related]  

  • 19. Indian regulations fail to monitor growing stem-cell use in clinics.
    Jayaraman KS
    Nature; 2005 Mar; 434(7031):259. PubMed ID: 15772610
    [No Abstract]   [Full Text] [Related]  

  • 20. "Commercial stem cells" damage medicine: medicine is aware.
    Bianco P
    Recenti Prog Med; 2015 Nov; 106(11):538-9. PubMed ID: 26668037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.